KRAS c.70A>T ;(p.I24F)

Variant ID: 12-25398249-T-A

NM_004985.3(KRAS):c.70A>T;(p.I24F)

This variant was identified in 1 publication

View GRCh38 version.



Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP

Publications:

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

Bmc Cancer
Pignochino, Ymera Y; Sarotto, Ivana I; Peraldo-Neia, Caterina C; Penachioni, Junia Y JY; Cavalloni, Giuliana G; Migliardi, Giorgia G; Casorzo, Laura L; Chiorino, Giovanna G; Risio, Mauro M; Bardelli, Alberto A; Aglietta, Massimo M; Leone, Francesco F
Publication Date: 2010-11-18

Variant appearance in text: KRAS: I24F
PubMed Link: 21087480
Variant Present in the following documents:
  • Main text
  • 1471-2407-10-631.pdf
View BVdb publication page